# Use of Tranexamic Acid in the Total Knee Arthroplasty.

> **NCT05919615** · NA · COMPLETED · sponsor: **Damascus University** · enrollment: 100 (actual)

## Conditions studied

- Knee Osteoarthritis
- Blood Loss
- Blood Transfusion

## Interventions

- **DRUG:** Tranexamic Acid 100 MG/ML
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT05919615
- **Lead sponsor:** Damascus University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-15
- **Primary completion:** 2023-03-15
- **Final completion:** 2023-03-15
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2023-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05919615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05919615, "Use of Tranexamic Acid in the Total Knee Arthroplasty.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05919615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*